William A. Curran
Lawyers
Filters
Livent $10.6 billion merger of equals with Allkem
We are advising Livent on the transaction
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
Virgin Orbit chapter 11 filing and DIP financing
We are advising Virgin Investments in connection with the restructuring and as DIP lender
Revlon chapter 11 plan confirmed
We are advising certain prepetition, DIP and exit financing lenders and equity backstop parties
Kenvue $7.75 billion senior notes offering
The investment-grade offering comprises eight tranches of notes
Marsh McLennan $600 million senior notes offering
We advised Marsh McLennan on its investment-grade notes offering
Mastercard $1.5 billion senior notes offering
We advised Mastercard on its investment-grade debt offering
HNI $485 million acquisition of Kimball International
We are advising HNI on the transaction
Assurant $175 million senior notes offering
We advised Assurant on the senior notes offering